106 filings
Page 5 of 6
6-K
kkhfbe0
12 Nov 19
Aslan Pharmaceuticals Announces Topline Results from Treetopp Global Pivotal Study of Varlitinib In Biliary Tract Cancer
6:03am
6-K
bqcjbs4m
5 Nov 19
Current report (foreign)
6:04am
6-K
vguqaa
31 Oct 19
Current report (foreign)
7:15am
6-K
5dzhe3q8 4l6h4
23 Oct 19
Current report (foreign)
6:07am
6-K
vg1xq 5p8xsweytd
18 Oct 19
Aslan Pharmaceuticals Announces Closing of US$3 Million Loan Facility
8:56am
6-K
slbazavgipgyz
7 Oct 19
Current report (foreign)
6:03am
6-K
33xfdwh b7m7
1 Oct 19
Aslan Pharmaceuticals and Bukwang Pharmaceutical Establish a Joint Venture, Jaguahr Therapeutics, to Develop Novel Immuno-oncology Therapies
6:33am
6-K
msmamfi7
28 Aug 19
New Data from Aslan’s Study of Varlitinib In China Accepted As Late-breaking Oral Presentation at 2019 Csco Annual Meeting
6:04am
6-K
wonzri9q13s
14 Aug 19
Aslan Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
12:00am
6-K
elhrwsw
29 Jul 19
Aslan Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of Chairman
6:11am
6-K
bys24 76wn
26 Jun 19
Current report (foreign)
6:04am
6-K
678ewi 2sl8
26 Jun 19
Current report (foreign)
6:03am
6-K
d2uzbhsodwxk vy3
17 Jun 19
Current report (foreign)
9:14am
6-K
mwgf 5oh714
10 Jun 19
Aslan Pharmaceuticals Completes Phase 1 Study for ASLAN004 Targeting Atopic Dermatitis
6:29am
6-K
vmx9ukp7t
30 Apr 19
Current report (foreign)
6:04am
6-K
g6lgilq qsk8frchf99
2 Apr 19
Aslan Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic Dermatitis
6:02am
6-K
xgt9uk
25 Mar 19
Current report (foreign)
6:03am
6-K
6omv0 hkpimen
12 Mar 19
Aslan Pharmaceuticals Signs New Agreement with Biogenetics for Commercialisation of ASLAN003 In South Korea
7:07am
6-K
y6djzm3ktrha254 40n
27 Feb 19
Aslan Pharmaceuticals to Partner with Biogenetics on Commercialisation of Varlitinib In South Korea
6:02am
6-K
bj4l 1nnthsx611t
30 Jan 19
Aslan Pharmaceuticals Announces Strategic Prioritisation of Clinical Development Programs and Corporate Restructuring
6:02am